Chargement en cours...
GEMCITABINE AND CISPLATIN IN UNRESECTABLE MALIGNANT MESOTHELIOMA OF THE PLEURA: A PHASE II STUDY OF THE SOUTHWEST ONCOLOGY GROUP (SWOG 9810)
PURPOSE: The purpose of this open- label phase II SWOG study was to evaluate the activity of gemcitabine (Gemzar ®; Eli Lilly, Indiana, USA) and cisplatin combination therapy, in patients with unresectable malignant mesothelioma of the pleura. PATIENTS AND METHODS: Fifty eligible chemotherapy naïve...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2702658/ https://ncbi.nlm.nih.gov/pubmed/18006112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2007.09.018 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|